Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert McShane

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
The Cochrane Database of Systematic Reviews|October 30, 2015
Pharmacological interventions for cognitive decline in people with Down syndromeNuala Livingstone, Jennifer Hanratty, Rupert McShane, et al.
Bjpsych Open|May 10, 2024
Guidelines for ketamine use in clinical psychiatry practiceLuke A Jelen, Rupert McShane, Allan H Young
Qualitative Health Research|August 12, 2017
Care, Control, and the Electroconvulsive Therapy Ritual: Making Sense of Polarized Patient NarrativesFauzia Knight, Damien Ridge, Rupert McShane, et al.
International Journal of Geriatric Psychiatry|July 30, 2009
Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodiesAnders Gustavsson, Rohan Van Der Putt, Linus Jönsson, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 12, 2021
Use of the Long-Term Conditions Questionnaire (LTCQ) for monitoring health-related quality of life in people affected by cognitive impairment including dementia: pilot study in UK memory clinic servicesCaroline M Potter, Michele Peters, Maureen Cundell, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 2, 2023
Living well while providing support: validation of LTCQ-Carer for assessing informal carers' quality of lifeCaroline M Potter, Michele Peters, Maureen Cundell, et al.
Journal of Anatomy|June 8, 2007
Alpha-synuclein pathology in the olfactory pathways of dementia patientsPaul S Hubbard, Margaret M Esiri, Margaret Reading, et al.
The Lancet. Psychiatry|April 12, 2017
Ketamine treatment for depression: opportunities for clinical innovation and ethical foresightIlina Singh, Celia Morgan, Valerie Curran, et al.
Bjpsych Open|September 19, 2019
Exploring patients' and carers' views about the clinical use of ketamine to inform policy and practical decisions: mixed-methods studySagar Jilka, Claire Murray, Ania Wieczorek, et al.
BMJ Open|August 18, 2019
Effects of ketamine treatment on suicidal ideation: a qualitative study of patients' accounts following treatment for depression in a UK ketamine clinicKaren Lascelles, Lisa Marzano, Fiona Brand, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
The Cochrane Database of Systematic Reviews|October 30, 2015
Pharmacological interventions for cognitive decline in people with Down syndromeNuala Livingstone, Jennifer Hanratty, Rupert McShane, et al.
Bjpsych Open|May 10, 2024
Guidelines for ketamine use in clinical psychiatry practiceLuke A Jelen, Rupert McShane, Allan H Young
Qualitative Health Research|August 12, 2017
Care, Control, and the Electroconvulsive Therapy Ritual: Making Sense of Polarized Patient NarrativesFauzia Knight, Damien Ridge, Rupert McShane, et al.
International Journal of Geriatric Psychiatry|July 30, 2009
Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodiesAnders Gustavsson, Rohan Van Der Putt, Linus Jönsson, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 12, 2021
Use of the Long-Term Conditions Questionnaire (LTCQ) for monitoring health-related quality of life in people affected by cognitive impairment including dementia: pilot study in UK memory clinic servicesCaroline M Potter, Michele Peters, Maureen Cundell, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 2, 2023
Living well while providing support: validation of LTCQ-Carer for assessing informal carers' quality of lifeCaroline M Potter, Michele Peters, Maureen Cundell, et al.
Journal of Anatomy|June 8, 2007
Alpha-synuclein pathology in the olfactory pathways of dementia patientsPaul S Hubbard, Margaret M Esiri, Margaret Reading, et al.
The Lancet. Psychiatry|April 12, 2017
Ketamine treatment for depression: opportunities for clinical innovation and ethical foresightIlina Singh, Celia Morgan, Valerie Curran, et al.
Bjpsych Open|September 19, 2019
Exploring patients' and carers' views about the clinical use of ketamine to inform policy and practical decisions: mixed-methods studySagar Jilka, Claire Murray, Ania Wieczorek, et al.
BMJ Open|August 18, 2019
Effects of ketamine treatment on suicidal ideation: a qualitative study of patients' accounts following treatment for depression in a UK ketamine clinicKaren Lascelles, Lisa Marzano, Fiona Brand, et al.
Pageof 7